Apimeds Pharmaceuticals US APUS
NYSE APUS
$2.88 -0.28 (-8.89%)
As of: Oct 23, 2026 · 2:44 PM EDT

Apimeds Pharmaceuticals US (APUS) Net Shares Issued and Repurchased (2025)

Updated

Analysis

Apimeds Pharmaceuticals US (APUS) Net Shares Issued and Repurchased (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued (Qtr)
1 Eli Lilly 1,129.96 Bn 1,098.54 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 635.65 Bn 555.51 Bn 17.30 Bn -966.00 Mn
3 AbbVie 504.89 Bn 478.00 Bn 12.70 Bn -9.00 Mn
4 Merck 358.50 Bn 312.87 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 291.04 Bn 255.03 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 265.27 Bn 238.95 Bn 12.86 Bn 6.00 Mn
7 Amgen 237.76 Bn 193.16 Bn 7.24 Bn -
8 Gilead Sciences 195.00 Bn 169.20 Bn 6.22 Bn -346.00 Mn
9 Pfizer 171.37 Bn 118.02 Bn 10.94 Bn -
10 Apimeds Pharmaceuticals US 4.93 Mn -14.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -323,319.00
Sep 30, 2025 323,319.00
API Access

Apimeds Pharmaceuticals US Net Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-shares-issued-and-repurchased&ticker=APUS&period=max&api_key=YOUR_API_KEY